NCT02045277

Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis

A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 212 (actual)
• Sponsor: Bausch Health Americas, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The objective of the study is to evaluate the safety and efficacy of a topical lotion

Detailed description

The objective of the study is to evaluate the safety and efficacy of a topical lotion when applied once daily to adult subjects with moderate to severe plaque psoriasis.

Conditions

• Plaque Psoriasis

Interventions

Type	Name	Description
DRUG	IDP-118 Lotion	Lotion
DRUG	IDP-118 Monad HP Lotion	Active Comparator
DRUG	IDP-118 Monad Taz Lotion	Active Comparator
DRUG	IDP-118 Vehicle Lotion	Vehicle

Timeline

• Start date: 2014-02-01
• Primary completion: 2014-11-01
• Completion: 2014-11-01
• First posted: 2014-01-24
• Last updated: 2020-08-20
• Results posted: 2020-08-20

Locations

18 sites across 1 country: United States